10 20 30 40 50 60 70 80 1J4L - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 03-OCT-01 1J4L
TITLE SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED TITLE 2 WITH A PHOSPHOTHREONYL PEPTIDE DERIVED FROM RAD9
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE SPK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL FHA DOMAIN (FHA2); COMPND 5 EC: 2.7.1.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: DNA REPAIR PROTEIN RAD9; COMPND 9 CHAIN: P; COMPND 10 FRAGMENT: RESIDUES 599-607; COMPND 11 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: SPK1 OR RAD53; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS PHOSPHOTHREONYL PEPTIDE WAS CHEMICALLY SOURCE 14 SYNTHESIZED.
KEYWDS FHA DOMAIN, RAD53, RAD9, PHOSPHOTHREONINE, PHOSPHOPROTEIN, KEYWDS 2 TRANSFERASE
EXPDTA SOLUTION NMR
AUTHOR I.-J.L.BYEON,S.YONGKIETTRAKUL,M.-D.TSAI
REVDAT 3 24-FEB-09 1J4L 1 VERSN REVDAT 2 01-APR-03 1J4L 1 JRNL REVDAT 1 05-DEC-01 1J4L 0
JRNL AUTH I.J.BYEON,S.YONGKIETTRAKUL,M.D.TSAI JRNL TITL SOLUTION STRUCTURE OF THE YEAST RAD53 FHA2 JRNL TITL 2 COMPLEXED WITH A PHOSPHOTHREONINE PEPTIDE PTXXL: JRNL TITL 3 COMPARISON WITH THE STRUCTURES OF FHA2-PYXL AND JRNL TITL 4 FHA1-PTXXD COMPLEXES. JRNL REF J.MOL.BIOL. V. 314 577 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11846568 JRNL DOI 10.1006/JMBI.2001.5141
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.WANG,I.J.BYEON,H.LIAO,K.D.BEEBE,S.YONGKIETTRAKUL, REMARK 1 AUTH 2 D.PEI,M.D.TSAI REMARK 1 TITL II. STRUCTURE AND SPECIFICITY OF THE INTERACTION REMARK 1 TITL 2 BETWEEN THE FHA2 DOMAIN OF RAD53 AND REMARK 1 TITL 3 PHOSPHOTYROSYL PEPTIDES. REMARK 1 REF J.MOL.BIOL. V. 302 927 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2000.4095 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.LIAO,I.J.BYEON,M.D.TSAI REMARK 1 TITL STRUCTURE AND FUNCTION OF A NEW REMARK 1 TITL 2 PHOSPHOPEPTIDE-BINDING DOMAIN CONTAINING THE FHA2 REMARK 1 TITL 3 OF RAD53. REMARK 1 REF J.MOL.BIOL. V. 294 1041 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1999.3313
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1J4L COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-OCT-01. REMARK 100 THE RCSB ID CODE IS RCSB001605.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293.00 REMARK 210 PH : 6.50 REMARK 210 IONIC STRENGTH : 10 MM SODIUM PHOSPHATE, 1 MM REMARK 210 DTT, AND 1 MM EDTA REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM FHA2 U-15N,13C 1.5 MM REMARK 210 PHOSPHOTHREONYL PEPTIDE OF REMARK 210 RAD9; 10 MM SODIUM REMARK 210 PHOSPHATE(PH 6.5), 1 MM DTT, REMARK 210 AND 1 MM EDTA REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY, 3D_ REMARK 210 15N-SEPARATED_NOESY, 2D_13C/ REMARK 210 15N-FILTERED_NOESY, 3D_13C - REMARK 210 EDITED_13C/15N-FILTERED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 2.6, X-PLOR 3.851 REMARK 210 METHOD USED : THE COMPLEX STRUCTURES ARE REMARK 210 GENERATED USING A TOTAL OF REMARK 210 3369 RESTRAINTS, 3181 DISTANCE REMARK 210 RESTRAINTS, AND 188 TALOS- REMARK 210 DERIVED DIHEDRAL ANGLE REMARK 210 RESTRAINTS. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE- RESONANCE REMARK 210 NMR SPECTROSCOPY.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 577 -55.52 -122.56 REMARK 500 PRO A 582 99.61 -47.24 REMARK 500 GLN A 589 56.41 -110.38 REMARK 500 TYR A 637 -69.96 68.42 REMARK 500 PRO A 640 -154.85 -61.93 REMARK 500 GLN A 642 -61.34 78.75 REMARK 500 LEU A 644 -162.12 -108.26 REMARK 500 VAL A 656 124.42 54.79 REMARK 500 ASN A 660 -82.76 55.72 REMARK 500 GLN A 666 101.85 -39.40 REMARK 500 ASN A 704 -52.09 -155.43 REMARK 500 GLU A 705 -36.09 146.92 REMARK 500 LEU A 710 -154.68 45.69 REMARK 500 GLN A 711 -76.60 14.08 REMARK 500 GLU A 712 96.84 -65.23 REMARK 500 ARG A 714 87.46 47.15 REMARK 500 GLU P 601 44.52 -166.59 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1J4L A 573 730 UNP P22216 RAD53_YEAST 573 730 DBREF 1J4L P 599 607 UNP P14737 RAD9_YEAST 599 607
SEQADV 1J4L TPO P 603 UNP P14737 THR 603 MODIFIED RESIDUE
SEQRES 1 A 158 GLY ASN GLY ARG PHE LEU THR LEU LYS PRO LEU PRO ASP SEQRES 2 A 158 SER ILE ILE GLN GLU SER LEU GLU ILE GLN GLN GLY VAL SEQRES 3 A 158 ASN PRO PHE PHE ILE GLY ARG SER GLU ASP CYS ASN CYS SEQRES 4 A 158 LYS ILE GLU ASP ASN ARG LEU SER ARG VAL HIS CYS PHE SEQRES 5 A 158 ILE PHE LYS LYS ARG HIS ALA VAL GLY LYS SER MET TYR SEQRES 6 A 158 GLU SER PRO ALA GLN GLY LEU ASP ASP ILE TRP TYR CYS SEQRES 7 A 158 HIS THR GLY THR ASN VAL SER TYR LEU ASN ASN ASN ARG SEQRES 8 A 158 MET ILE GLN GLY THR LYS PHE LEU LEU GLN ASP GLY ASP SEQRES 9 A 158 GLU ILE LYS ILE ILE TRP ASP LYS ASN ASN LYS PHE VAL SEQRES 10 A 158 ILE GLY PHE LYS VAL GLU ILE ASN ASP THR THR GLY LEU SEQRES 11 A 158 PHE ASN GLU GLY LEU GLY MET LEU GLN GLU GLN ARG VAL SEQRES 12 A 158 VAL LEU LYS GLN THR ALA GLU GLU LYS ASP LEU VAL LYS SEQRES 13 A 158 LYS LEU SEQRES 1 P 9 GLU VAL GLU LEU TPO GLN GLU LEU PRO
MODRES 1J4L TPO P 603 THR PHOSPHOTHREONINE
HET TPO P 603 17
HETNAM TPO PHOSPHOTHREONINE
HETSYN TPO PHOSPHONOTHREONINE
FORMUL 2 TPO C4 H10 N O6 P
HELIX 1 1 THR A 720 LYS A 729 1 10
SHEET 1 A 6 LEU A 592 ILE A 594 0 SHEET 2 A 6 LEU A 578 PRO A 582 -1 N LEU A 580 O LEU A 592 SHEET 3 A 6 PHE A 692 ILE A 696 -1 O GLU A 695 N THR A 579 SHEET 4 A 6 ASP A 676 LYS A 679 -1 N ASP A 676 O VAL A 694 SHEET 5 A 6 SER A 657 LEU A 659 -1 N TYR A 658 O LYS A 679 SHEET 6 A 6 ASN A 662 MET A 664 -1 O ASN A 662 N LEU A 659 SHEET 1 B 6 CYS A 611 LYS A 612 0 SHEET 2 B 6 PHE A 601 GLY A 604 1 N GLY A 604 O CYS A 611 SHEET 3 B 6 CYS A 623 HIS A 630 -1 O ILE A 625 N PHE A 601 SHEET 4 B 6 LEU A 644 HIS A 651 -1 O ASP A 646 N LYS A 628 SHEET 5 B 6 THR A 668 LEU A 671 -1 O PHE A 670 N TYR A 649 SHEET 6 B 6 LEU A 717 LYS A 718 -1 O LEU A 717 N LYS A 669
LINK C LEU P 602 N TPO P 603 1555 1555 1.33 LINK C TPO P 603 N GLN P 604 1555 1555 1.33
CISPEP 1 ASN A 599 PRO A 600 0 0.56
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000